Evidence map›Paper›PMID 40561161›Full record

ArticlePloS one2025

Drivers of Lassa fever in an endemic area of southwestern Nigeria (2017-2021): An epidemiological study.

Simeon Cadmus, Victor Akinseye, Eniola Cadmus, Gboyega Famokun, Stephen Fagbemi, Gabriel Ogunde, Ayuba Philip, Rashid Ansumana, Adekunle Ayinmode, Olalekan Taiwo and 3 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Simeon CadmusDepartment of Veterinary Public Health and Preventive Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0000-0002-3281-2316
Victor AkinseyeDamien Foundation Genomic and Mycobacteria Research and Training Centre, University of Ibadan, Ibadan, Nigeria.
Eniola CadmusDepartment of Community Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Gboyega FamokunDepartment of Epidemiology and Disease Control, Ondo State Ministry of Health, Akure, Ondo State, Nigeria.
Stephen FagbemiDepartment of Epidemiology and Disease Control, Ondo State Ministry of Health, Akure, Ondo State, Nigeria.
Gabriel OgundeDepartment of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0000-0002-6986-964X
Ayuba PhilipFederal Ministry of Agriculture and Rural Development, Abuja, Nigeria.
Rashid AnsumanaSchool of Community Health Sciences, Njala University, Bo, Sierra Leone.
Adekunle AyinmodeCentre for Control and Prevention of Zoonoses, University of Ibadan, Ibadan, Nigeria.
Olalekan TaiwoDepartment of Geography, University of Ibadan, Ibadan, Nigeria.
Daniel OluwayeluCentre for Control and Prevention of Zoonoses, University of Ibadan, Ibadan, Nigeria.
Oyewale TomoriAfrican Centre of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria.
Solomon OdemuyiwaCentre for Control and Prevention of Zoonoses, University of Ibadan, Ibadan, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReporting two million human Lassa fever (LF) cases with around 10,000 associated annual mortality, the West African sub-region is endemic for Lassa fever virus (LASV). The true incidence of LF is difficult to determine because most LASV-infected individuals show no differentiating clinical signs and symptoms. We investigated the distribution of cases, post-hospitalization survival patterns, and evaluated factors contributing to infection and clinical course of the disease during an outbreak of LF in Ondo State, Nigeria, from 2017 to 2021.

methodsWe extracted LF data from the Integrated Disease Surveillance and Response weekly report of the Nigerian Centre for Disease Control for 2017-2021. Kaplan-Meier estimate was used to describe the probability of survival among the LF cases. Also, a univariable binary logistic regression was used to explore factors associated with mortality among the study participants. Key informant was interviewed and environmental assessments were also done.

resultsLASV infection was confirmed in 1,115 (24.5%) of 4,551 cases with clinical signs suggestive of LF (age 35.24 ± 20.77) and case fatality rate of 25.5%. Hospitalized patients who did not recover within 17 days had less than 50% chance of survival. Age is a strong predictor of survival; hospitalized patients >40 years were significantly more likely than younger ones to experience mortality (Odds ratio:2.46; 95% CI = 1.67-3.62; p < 0.01). Similarly, male patients were significantly less likely than the females to survive beyond 10 days of hospitalization. Open sun drying of food items and congested urban residential settings with history of frequent rat sightings are possible factors for the increase of LF cases in the study area.

conclusionCurrent case definition in Ondo State identified close to 25% of laboratory confirmed LASV infection. Human activities during the dry season (October-March) are associated with increased LF cases. We propose a One Health disease surveillance approach that synchronizes farming activities with educational campaigns as a mitigation strategy against LASV infection and mortality in Nigeria.

Indexed as

Endemic DiseasesLassa FeverAdolescentAdultAgedAnimalsChildChild, PreschoolDisease OutbreaksFemaleHumansIncidenceInfantLassa virusMaleMiddle Aged

Identifiers

PMID40561161
PMCPMC12193570

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.